Vivo Bio Tech Limited (BOM:511509)
39.26
-0.74 (-1.85%)
At close: Apr 25, 2025
Vivo Bio Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 13.9 | 13.75 | 17.14 | 11.65 | 10.29 | Upgrade
|
Cash & Short-Term Investments | 13.7 | 13.9 | 13.75 | 17.14 | 11.65 | 10.29 | Upgrade
|
Cash Growth | -14.28% | 1.08% | -19.77% | 47.03% | 13.30% | 82.81% | Upgrade
|
Accounts Receivable | - | 117.95 | 123.8 | 120.24 | 72.93 | 104.82 | Upgrade
|
Other Receivables | - | 10.58 | 32.28 | 8.89 | - | - | Upgrade
|
Receivables | - | 363.21 | 216.5 | 136.25 | 101.78 | 147.42 | Upgrade
|
Inventory | - | 87.74 | 79.73 | 98.12 | 132.77 | 105.79 | Upgrade
|
Other Current Assets | - | 7.48 | 7.94 | 8.81 | 24.66 | 5.72 | Upgrade
|
Total Current Assets | - | 472.32 | 317.91 | 260.32 | 270.87 | 269.21 | Upgrade
|
Property, Plant & Equipment | - | 814.65 | 799.62 | 824.13 | 410.35 | 287.66 | Upgrade
|
Other Intangible Assets | - | 81.21 | 108.06 | 136.24 | 113.36 | 63.75 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | - | 15.48 | Upgrade
|
Long-Term Deferred Charges | - | 3.16 | 4.73 | 4.17 | 0.65 | 0.78 | Upgrade
|
Other Long-Term Assets | - | 0 | 0 | - | - | - | Upgrade
|
Total Assets | - | 1,371 | 1,230 | 1,225 | 795.23 | 636.89 | Upgrade
|
Accounts Payable | - | 10.6 | 9.42 | 23.16 | 13.88 | 39.14 | Upgrade
|
Accrued Expenses | - | 37.87 | 36.92 | 27.46 | 27.84 | 4.31 | Upgrade
|
Short-Term Debt | - | 226.79 | 115.87 | 109.19 | 163.07 | 146.75 | Upgrade
|
Current Portion of Long-Term Debt | - | 85.98 | 77.17 | 64.41 | - | - | Upgrade
|
Current Income Taxes Payable | - | 17.91 | 10.31 | 7.59 | 13.58 | - | Upgrade
|
Other Current Liabilities | - | -0 | 0 | - | - | 15.42 | Upgrade
|
Total Current Liabilities | - | 379.15 | 249.69 | 231.81 | 218.37 | 205.62 | Upgrade
|
Long-Term Debt | - | 417.87 | 430.92 | 500.78 | 146.5 | 96.87 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 23.42 | 24.85 | 15.44 | 0.31 | - | Upgrade
|
Other Long-Term Liabilities | - | 0 | -0 | 0 | - | - | Upgrade
|
Total Liabilities | - | 827.34 | 711.6 | 753.57 | 369.96 | 306.65 | Upgrade
|
Common Stock | - | 149.04 | 149.04 | 142.64 | 134.2 | 128.88 | Upgrade
|
Additional Paid-In Capital | - | 149.58 | 149.58 | 128.13 | 105.2 | 86.58 | Upgrade
|
Retained Earnings | - | 216.13 | 190.87 | 164.38 | 142.36 | 85.54 | Upgrade
|
Comprehensive Income & Other | - | 29.25 | 29.25 | 36.15 | 43.51 | 29.25 | Upgrade
|
Shareholders' Equity | 597.99 | 544 | 518.73 | 471.28 | 425.27 | 330.24 | Upgrade
|
Total Liabilities & Equity | - | 1,371 | 1,230 | 1,225 | 795.23 | 636.89 | Upgrade
|
Total Debt | 578.83 | 730.64 | 623.96 | 674.39 | 309.57 | 243.62 | Upgrade
|
Net Cash (Debt) | -565.13 | -716.74 | -610.21 | -657.25 | -297.91 | -233.34 | Upgrade
|
Net Cash Per Share | -33.83 | -42.97 | -41.16 | -46.40 | -21.97 | -18.11 | Upgrade
|
Filing Date Shares Outstanding | 14.91 | 14.9 | 14.9 | 14.26 | 13.42 | 12.89 | Upgrade
|
Total Common Shares Outstanding | 14.91 | 14.9 | 14.9 | 14.26 | 13.42 | 12.89 | Upgrade
|
Working Capital | - | 93.17 | 68.22 | 28.51 | 52.5 | 63.6 | Upgrade
|
Book Value Per Share | 40.11 | 36.50 | 34.81 | 33.04 | 31.69 | 25.62 | Upgrade
|
Tangible Book Value | 530.21 | 462.79 | 410.67 | 335.05 | 311.91 | 266.49 | Upgrade
|
Tangible Book Value Per Share | 35.56 | 31.05 | 27.56 | 23.49 | 23.24 | 20.68 | Upgrade
|
Land | - | 228.8 | 228.8 | 228.8 | 26.99 | 26.99 | Upgrade
|
Buildings | - | 174.89 | 174.89 | 174.89 | 31.66 | 31.66 | Upgrade
|
Machinery | - | 751.87 | 747.18 | 717.51 | 604.69 | 447.83 | Upgrade
|
Construction In Progress | - | 92.12 | 18.97 | 8.66 | 3.25 | 1.54 | Upgrade
|
Updated Jan 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.